Humacyte Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Humacyte, Inc. (HUMA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-148.70-110.78-11.97-26.48-66.52
Depreciation & Amortization7.197.729.858.248.35
Stock Based Compensation6.146.836.1810.154.69
Change in Working Capital0.316.571.25-0.56-2.37
Change in Accounts Receivable0.000.030.15-0.060.49
Change in Accounts Payable-1.964.81-0.51-0.20-0.89
Change in Other Working Capital2.2713.65-74.18-0.30-1.97
Other Operating Activities36.9413.655.72-73.520.10
Net Cash from Operating Activities-98.12-73.31-71.13-81.19-55.57
Investing Activities
Capital Expenditures-1.57-2.281.05-0.22-0.32
Acquisitions0.0010.02-75.77-55.770.00
Purchases of Investments0.002.11-10.11-8.000.00
Sales/Maturities of Investments0.002.115.89-8.000.00
Net Cash from Investing Activities-1.57-0.174.85-8.22-0.27
Financing Activities
Debt Repayment-2.58-34.07-1.98-1.730.00
Common Stock Issued94.840.570.54243.000.30
Other Financing Activities21.9238.010.00-3.950.00
Net Cash from Financing Activities114.184.51-1.45266.982.05
Summary
Net Change in Cash14.49-68.97-67.73177.57-53.78
Cash at Beginning of Period80.80149.77217.5039.930.00
Cash at End of Period95.2980.80149.77217.500.00
Free Cash Flow-99.69-75.59-72.15-81.41-55.89
Supplemental Disclosures
Interest Paid0.001.612.671.120.00